BioAffinity prices 1.92M common share offering at $2.50 per share

bioAffinity Technologies (BIAF) announced that it has priced a public offering of securities for aggregate gross proceeds to the company of $4.8M, before deducting agent fees and other estimated expenses payable by the company. The offering consists of 1.92M shares of common stock at a purchase price of $2.50 per share. The closing of the offering is expected to occur on or about September 30, subject to the satisfaction of customary closing conditions. WallachBeth Capital is acting as sole placement agent for the offering.